Options Brief: MannKind

Shares of MannKind MNKD are higher on the session by 20.67%, trading at $2.86. Overall call volume is now running at 2.94x the daily average, with 51% of all calls traded being purchases on the offer. 5,507 contracts have traded on the session so far. MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date of Trade
ticker
Put/Call
Strike Price
DTE
Sentiment
Posted In: OptionsBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!